Market Currents
Complete Genomics (GNOM) tacks on another 2.2% gain premarket after surging yesterday on news...
-
Tuesday, February 14, 2012, 9:15 AM ETComplete Genomics (GNOM) tacks on another 2.2% gain premarket after surging yesterday on news that the Mayo Clinic will outsource whole human genome sequencing to the company. Shares are now up 59% YTD, but still trade at only a third of their 52-week highs.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
